Volume 34 Number 3 | 2019
- 2020 license and registration renewals
- Notice - Licensee Portal
- Welcome to new employees
- ALBME social media guidelines
- Starting Nov. 18 Gabapentin will be a Schedule V drug
- Administrative rule changes
- Public actions of the Board and Commission